International Patient Summary Implementation Guide
2.0.0 - STU 2
International Patient Summary Implementation Guide
2.0.0 - STU 2
International Patient Summary Implementation Guide, published by HL7 International / Patient Care. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ips/ and changes regularly. See the Directory of published versions
Document Details
Language: en-NZ
Profile: Bundle (IPS)
Security Label: normal (Details: Confidentiality code N = 'normal')
Final Document at 2024-09-13 by Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 for Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000
Document Content
Generated Narrative: Composition 9c98f78e-f324-4ad5-97a1-8eb9ef9a1172
version: 1; Language: en-NZ
Profile: Composition (IPS)
identifier: urn:oid:2.16.840.1.113883.2.18.7.2/ac7a747c-a2c9-493c-ba39-4ac6997eed1e
status: Final
type: Patient summary Document
date: 2024-09-13
title: International Patient Summary
confidentiality: normal
| Mode | Time | Party |
| Professional | 2024-09-13 | Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 |
| Code | Target[x] |
| Transforms | urn:oid:2.16.840.1.113883.2.18.7.2/ac7a747c-a2c9-493c-ba39-4ac6997eed1e |
| Code | Period |
| care provision | ?? --> 2024-09-13 |
| Problem | Onset | Clinical Status | Verification Status | Severity |
|---|---|---|---|---|
| Essential hypertension | May 24 2016 20:00 | |||
| Gout | May 24 2016 20:00 |
| Allergy Type | Substance | Onset | Clinical Status | Verification Status | Reaction |
|---|---|---|---|---|---|
| Penicillin |
| Medication | Dates | Dosage-Timing | Status | Route |
|---|---|---|---|---|
| cilazapril 500 microgram tablet, 90 | stopped | |||
| lisinopril 5 mg tablet | active | |||
| Ultraproct - cinchocaine 0.5% (5 mg/g) + fluocortolone hexanoate 0.095% (945 microgram/g) + fluocortolone pivalate 0.092% (918 microgram/g) ointment | active |
| Vaccine | Date | Status | Lot Number |
|---|---|---|---|
| Influenza, split virus, trivalent, preservative | Apr 9 2024 20:00 | Completed | H06 |
| COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose | Feb 17 2024 19:00 | Completed | GK3908-068 |
| Influenza, split virus, trivalent, preservative | Apr 11 2023 20:00 | Completed | 358899 |
| COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | Jul 31 2022 20:00 | Completed | PCB0008-07 |
| zoster live | Jul 12 2022 20:00 | Completed | U021248 |
| COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | Jan 12 2022 19:00 | Completed | FL1072-025 |
| COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | Aug 26 2021 20:00 | Completed | FE8163-007 |
| COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | Aug 4 2021 20:00 | Completed | FF8871-001 |
| Result | Value | Date | Status |
|---|---|---|---|
| Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma | 4.1 mmol/L | Oct 31 2023 11:06 | final |
| Lipid risk factors [Finding] | A combined CVD risk of which lipids is one component should be estimated to guide CVD risk management decisions. If lipid modifying medication is considered suggest checking first for treatable secondary causes of dyslipidaemia. | Oct 31 2023 11:06 | final |
| Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation | 3.6 mmol/L | Oct 31 2023 11:06 | final |
| Triglyceride [Moles/volume] in Serum or Plasma | 1.7 mmol/L | Oct 31 2023 11:06 | final |
| Cholesterol [Moles/volume] in Serum or Plasma | 5.7 mmol/L | Oct 31 2023 11:06 | final |
| Cholesterol in HDL [Moles/volume] in Serum or Plasma | 1.39 mmol/L | Oct 31 2023 11:06 | final |
| Procedure | Date | Status |
|---|---|---|
| Total hip replacement | Apr 27 2000 20:00 | Completed |
| Device | Status | Body Site | Start | End |
|---|---|---|---|---|
| Hip prosthesis | active |
| Vital Sign | Value | Date | Status |
|---|---|---|---|
| Body weight | 91.5 kg | Apr 10 2024 05:58 | final |
| Body mass index (BMI) [Ratio] | 24.56 kg/m2 | Apr 10 2024 05:58 | final |
| Blood pressure panel with all children optional | 140/80 mmHg | Aug 30 2024 04:32 | final |
| Social History Observation | Value | Date | Status |
|---|---|---|---|
| Tobacco smoking status | Never smoker | Oct 19 2022 20:00 | final |
| Alcoholic drinks per day | 1 d | Jun 21 2016 20:00 | final |
| Alert | Status | Category | Priority | Start | End |
|---|---|---|---|---|---|
| Shellfish free diet | Active | Diet |
| Scope | Status | Category | Date | Performer |
|---|---|---|---|---|
| Treatment | active | Do Not Resuscitate | Aug 31 2021 20:00 |
| Code | Onset | Clinical Status | Verification Status | Severity |
|---|---|---|---|---|
| Impaired Mobility | May 24 2016 20:00 |
| Past Problem | Onset | Clinical Status | Verification Status | Severity |
|---|---|---|---|---|
| Fever | May 24 2013 20:00 |
| Pregnancy Observation | Value | Date | Status |
|---|---|---|---|
| Pregnancy status | Not Pregnant | Jan 9 2020 19:00 | final |
| Title | Description | Status | Intent | Category | Period Start | Period End |
|---|---|---|---|---|---|---|
| Weight Measured | Manage obesity and weight loss | Active | Plan | Weight management plan | May 31 2017 20:00 |
Entry 2 - fullUrl = https://sample.fhir.org/Patient/d174bd1a-b368-41e6-83a2-af77f2b3c60f
Resource Patient:
Name: Patricia JORDANA
Entry 3 - fullUrl = https://sample.fhir.org/Organization/7a17027f-acc0-4d77-bf84-c0dad8f7c881
Resource Organization:
Generated Narrative: Organization 7a17027f-acc0-4d77-bf84-c0dad8f7c881
identifier:
https://standards.digital.health.nz/ns/hpi-facility-id/F2N000name: NorthCare Pukete Road-Thomas Road
Entry 4 - fullUrl = https://sample.fhir.org/Organization/8f8635dc-694e-408f-8ffe-1610d50f9823
Resource Organization:
Generated Narrative: Organization 8f8635dc-694e-408f-8ffe-1610d50f9823
identifier:
https://standards.digital.health.nz/ns/hpi-facility-id/F2N001name: NorthCare Health System
Entry 5 - fullUrl = https://sample.fhir.org/PractitionerRole/94d12c8d-a3df-47a7-a0bb-0f29d64bafe2
Resource PractitionerRole:
Generated Narrative: PractitionerRole 94d12c8d-a3df-47a7-a0bb-0f29d64bafe2
code: Doctor
Entry 6 - fullUrl = https://sample.fhir.org/Practitioner/816cf057-b736-4e08-baed-cc21e081b784
Resource Practitioner:
Generated Narrative: Practitioner 816cf057-b736-4e08-baed-cc21e081b784
name: HASHIRA COORAY COORAY
telecom: ph: 07 850 9900(Work)
Entry 7 - fullUrl = https://sample.fhir.org/AllergyIntolerance/9838cf73-c30d-4aa5-8ed8-36a079060b81
Resource AllergyIntolerance:
Generated Narrative: AllergyIntolerance 9838cf73-c30d-4aa5-8ed8-36a079060b81
clinicalStatus: Active
verificationStatus: Confirmed
code: Penicillin
Entry 8 - fullUrl = https://sample.fhir.org/Condition/8039e4a7-d459-454c-92a5-6c17ca2a824b
Resource Condition:
Generated Narrative: Condition 8039e4a7-d459-454c-92a5-6c17ca2a824b
clinicalStatus: Active
verificationStatus: Confirmed
code: Essential hypertension
onset: 2016-05-25
recordedDate: 2016-05-25
Entry 9 - fullUrl = https://sample.fhir.org/Condition/f8ab8ac1-56d1-4239-8303-dc70c1a3d0e1
Resource Condition:
Generated Narrative: Condition f8ab8ac1-56d1-4239-8303-dc70c1a3d0e1
clinicalStatus: Active
verificationStatus: Confirmed
code: Gout
onset: 2016-05-25
recordedDate: 2020-10-01
Entry 10 - fullUrl = https://sample.fhir.org/MedicationStatement/c3d31980-2a88-45b6-a7af-3fe8d32cc6fa
Resource MedicationStatement:
Generated Narrative: MedicationStatement c3d31980-2a88-45b6-a7af-3fe8d32cc6fa
status: Stopped
medication: cilazapril 500 microgram tablet, 90
effective: 2023-12-01
informationSource: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000
dosage
text: Take 1 daily
DoseAndRates
Dose[x] 1 tablet (Details: SNOMED CT code428673006 = 'Tablet - unit of product usage (qualifier value)')
Entry 11 - fullUrl = https://sample.fhir.org/MedicationStatement/b8dac343-16d7-49bf-ac36-b15e6726c343
Resource MedicationStatement:
Generated Narrative: MedicationStatement b8dac343-16d7-49bf-ac36-b15e6726c343
status: Active
medication: lisinopril 5 mg tablet
effective: 2024-08-13
informationSource: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000
dosage
text: Take One tablet once daily
timing: Once per 1 day
route: Swallow, oral
DoseAndRates
Dose[x] 1 tablet (Details: SNOMED CT code428673006 = 'Tablet - unit of product usage (qualifier value)')
Entry 12 - fullUrl = https://sample.fhir.org/MedicationStatement/b8e4d4a8-2c18-4f03-88dc-06f5f44f8058
Resource MedicationStatement:
Generated Narrative: MedicationStatement b8e4d4a8-2c18-4f03-88dc-06f5f44f8058
status: Active
medication: Ultraproct - cinchocaine 0.5% (5 mg/g) + fluocortolone hexanoate 0.095% (945 microgram/g) + fluocortolone pivalate 0.092% (918 microgram/g) ointment
effective: 2024-08-30
informationSource: Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000
dosage
text: apply a small amount to the affected area up to 4 times daily on the first day, then twice daily for at least 1 week; continue for up to a maximum of 4 weeks
DoseAndRates
Dose[x] 1 ointment (Details: SNOMED CT code385101003 = 'Ointment')
Entry 13 - fullUrl = https://sample.fhir.org/Immunization/17b5a6d7-307b-4726-8c8c-0031e61582ce
Resource Immunization:
Generated Narrative: Immunization 17b5a6d7-307b-4726-8c8c-0031e61582ce
status: Completed
vaccineCode: Influenza, split virus, trivalent, preservative
occurrence: 2024-04-10
lotNumber: H06
site: Structure of left deltoid muscle
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 1 (Over 65 years (Influenza)) 1
Entry 14 - fullUrl = https://sample.fhir.org/Immunization/14e8b0d8-b4e4-4f8e-b263-ef385787453b
Resource Immunization:
Generated Narrative: Immunization 14e8b0d8-b4e4-4f8e-b263-ef385787453b
status: Completed
vaccineCode: COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose
occurrence: 2024-02-18
lotNumber: GK3908-068
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 6 (Booster or Extra dose) 5
Entry 15 - fullUrl = https://sample.fhir.org/Immunization/47befa30-026c-421a-ad32-c0b134597a30
Resource Immunization:
Generated Narrative: Immunization 47befa30-026c-421a-ad32-c0b134597a30
status: Completed
vaccineCode: Influenza, split virus, trivalent, preservative
occurrence: 2023-04-12
lotNumber: 358899
site: Structure of right deltoid muscle
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 1 (Over 65 years (Influenza)) 1
Entry 16 - fullUrl = https://sample.fhir.org/Immunization/2f05b590-ce75-4ac6-be97-c2a275e21cbc
Resource Immunization:
Generated Narrative: Immunization 2f05b590-ce75-4ac6-be97-c2a275e21cbc
status: Completed
vaccineCode: COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
occurrence: 2022-08-01
lotNumber: PCB0008-07
site: Structure of left deltoid muscle
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 12 (At risk, no previous history) 4
Entry 17 - fullUrl = https://sample.fhir.org/Immunization/c1d3ccb9-8b7d-4732-8e03-abe63be1984c
Resource Immunization:
Generated Narrative: Immunization c1d3ccb9-8b7d-4732-8e03-abe63be1984c
status: Completed
vaccineCode: zoster live
occurrence: 2022-07-13
lotNumber: U021248
site: Entire left upper arm
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 65Y (65 years) 1
Entry 18 - fullUrl = https://sample.fhir.org/Immunization/79b66c21-fbd3-4c7f-ae82-ac958ae62e0a
Resource Immunization:
Generated Narrative: Immunization 79b66c21-fbd3-4c7f-ae82-ac958ae62e0a
status: Completed
vaccineCode: COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
occurrence: 2022-01-13
lotNumber: FL1072-025
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 12 (At risk, no previous history) 3
Entry 19 - fullUrl = https://sample.fhir.org/Immunization/9910b96a-793b-4e96-91a9-291c27357f83
Resource Immunization:
Generated Narrative: Immunization 9910b96a-793b-4e96-91a9-291c27357f83
status: Completed
vaccineCode: COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
occurrence: 2021-08-27
lotNumber: FE8163-007
site: Structure of left deltoid muscle
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 12 (At risk, no previous history) 2
Entry 20 - fullUrl = https://sample.fhir.org/Immunization/5b028fb0-bd04-4e75-b2bc-6952771173ea
Resource Immunization:
Generated Narrative: Immunization 5b028fb0-bd04-4e75-b2bc-6952771173ea
status: Completed
vaccineCode: COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
occurrence: 2021-08-05
lotNumber: FF8871-001
site: Structure of left deltoid muscle
route: Injection, intramuscular
Performers
Actor Bundle: identifier = urn:oid:2.16.724.4.8.10.200.10#ac7a747c-a2c9-493c-ba39-4ac6997eed1e; type = document; timestamp = 2024-09-21 18:53:00+0000 ProtocolApplieds
Series DoseNumber[x] 12 (At risk, no previous history) 1
Entry 21 - fullUrl = https://sample.fhir.org/Observation/b0187efd-5f9b-474d-87bc-efebf877449a
Resource Observation:
Generated Narrative: Observation b0187efd-5f9b-474d-87bc-efebf877449a
status: Final
category: Laboratory
code: Cholesterol.total/Cholesterol in HDL [Molar ratio] in Serum or Plasma
effective: 2023-10-31 15:06:00+0000
value: 4.1 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
note:
Incr chol 5.7, LDL 3.6, HDL 1.39
ReferenceRanges
Text NA
Entry 22 - fullUrl = https://sample.fhir.org/Observation/f40b9e26-93b4-462b-8811-bdd6943873aa
Resource Observation:
Generated Narrative: Observation f40b9e26-93b4-462b-8811-bdd6943873aa
status: Final
category: Laboratory
code: Lipid risk factors [Finding]
effective: 2023-10-31 15:06:00+0000
value: A combined CVD risk of which lipids is one component should be estimated to guide CVD risk management decisions. If lipid modifying medication is considered suggest checking first for treatable secondary causes of dyslipidaemia.
note:
Incr chol 5.7, LDL 3.6, HDL 1.39
ReferenceRanges
Text NA
Entry 23 - fullUrl = https://sample.fhir.org/Observation/612b7e6a-c902-45cb-b45c-d1894458a26b
Resource Observation:
Generated Narrative: Observation 612b7e6a-c902-45cb-b45c-d1894458a26b
status: Final
category: Laboratory
code: Cholesterol in LDL [Moles/volume] in Serum or Plasma by calculation
effective: 2023-10-31 15:06:00+0000
value: 3.6 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
note:
Incr chol 5.7, LDL 3.6, HDL 1.39
ReferenceRanges
Text NA
Entry 24 - fullUrl = https://sample.fhir.org/Observation/15bd8c0c-fa53-4f5b-994b-487c7db3dc78
Resource Observation:
Generated Narrative: Observation 15bd8c0c-fa53-4f5b-994b-487c7db3dc78
status: Final
category: Laboratory
code: Triglyceride [Moles/volume] in Serum or Plasma
effective: 2023-10-31 15:06:00+0000
value: 1.7 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
note:
Incr chol 5.7, LDL 3.6, HDL 1.39
ReferenceRanges
Text NA
Entry 25 - fullUrl = https://sample.fhir.org/Observation/5019909f-097d-4a43-84d9-cc50143b8c82
Resource Observation:
Generated Narrative: Observation 5019909f-097d-4a43-84d9-cc50143b8c82
status: Final
category: Laboratory
code: Cholesterol [Moles/volume] in Serum or Plasma
effective: 2023-10-31 15:06:00+0000
value: 5.7 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
note:
Incr chol 5.7, LDL 3.6, HDL 1.39
ReferenceRanges
Text NA
Entry 26 - fullUrl = https://sample.fhir.org/Observation/5d269392-79c1-4129-a142-0cdee6b49ea4
Resource Observation:
Generated Narrative: Observation 5d269392-79c1-4129-a142-0cdee6b49ea4
status: Final
category: Laboratory
code: Cholesterol in HDL [Moles/volume] in Serum or Plasma
effective: 2023-10-31 15:06:00+0000
value: 1.39 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
note:
Incr chol 5.7, LDL 3.6, HDL 1.39
ReferenceRanges
Text NA
Entry 27 - fullUrl = https://sample.fhir.org/Observation/36ff59b8-d5a7-438e-b8c6-cd54af10a4af
Resource Observation:
Generated Narrative: Observation 36ff59b8-d5a7-438e-b8c6-cd54af10a4af
status: Final
category: Vital Signs
code: Body weight
effective: 2024-04-10 09:58:00+0000
value: 91.5 kg (Details: UCUM codekg = 'kg')
Entry 28 - fullUrl = https://sample.fhir.org/Observation/96e33a60-dbd8-47ce-b613-be954243939e
Resource Observation:
Generated Narrative: Observation 96e33a60-dbd8-47ce-b613-be954243939e
status: Final
category: Vital Signs
code: Body mass index (BMI) [Ratio]
effective: 2024-04-10 09:58:00+0000
value: 24.56 kg/m2 (Details: UCUM codekg/m2 = 'kg/m2')
Entry 29 - fullUrl = https://sample.fhir.org/Observation/4ea539e1-fff9-4f56-964f-650d9e69ce58
Resource Observation:
Generated Narrative: Observation 4ea539e1-fff9-4f56-964f-650d9e69ce58
status: Final
category: Vital Signs
code: Blood pressure panel with all children optional
effective: 2024-08-30 08:32:00+0000
component
code: Systolic blood pressure
value: 140 mmHg (Details: UCUM codemm[Hg] = 'mm[Hg]')
component
code: Diastolic blood pressure
value: 80 mmHg (Details: UCUM codemm[Hg] = 'mm[Hg]')
Entry 30 - fullUrl = https://sample.fhir.org/Observation/9f906425-8c18-4580-ab30-61a56d7f4c05
Resource Observation:
Generated Narrative: Observation 9f906425-8c18-4580-ab30-61a56d7f4c05
status: Final
category: Social History
code: Tobacco smoking status
effective: 2022-10-20
value: Never smoker
Entry 31 - fullUrl = https://sample.fhir.org/Observation/e2e3f8aa-df2a-4357-b01f-a9fba6bb9b41
Resource Observation:
Generated Narrative: Observation e2e3f8aa-df2a-4357-b01f-a9fba6bb9b41
status: Final
category: Social History
code: Alcoholic drinks per day
effective: 2016-06-22
value: 1 d (Details: UCUM coded = 'd')
Entry 32 - fullUrl = https://sample.fhir.org/PractitionerRole/75ed6f24-9a7e-4568-9c05-91b6d4786743
Resource PractitionerRole:
Generated Narrative: PractitionerRole 75ed6f24-9a7e-4568-9c05-91b6d4786743
code: Clinical pathologist
Entry 33 - fullUrl = https://sample.fhir.org/Flag/e8ae9c4e-8f5a-4270-bfac-02368c567fcf
Resource Flag:
Generated Narrative: Flag e8ae9c4e-8f5a-4270-bfac-02368c567fcf
status: Active
category: Diet
code: Shellfish free diet
Entry 34 - fullUrl = https://sample.fhir.org/Procedure/39252
Resource Procedure:
Generated Narrative: Procedure 39252
status: Completed
code: Total hip replacement
performed: 2000-04-28
Entry 35 - fullUrl = https://sample.fhir.org/DeviceUseStatement/eumfh-70-275-1
Resource DeviceUseStatement:
Generated Narrative: DeviceUseStatement eumfh-70-275-1
status: Active
timing: Absent because : unknown
device: Hip prosthesis
Entry 36 - fullUrl = https://sample.fhir.org/Device/eumfh-70-275-2
Resource Device:
Generated Narrative: Device eumfh-70-275-2
type: Hip prosthesis, device (physical object)
Entry 37 - fullUrl = https://sample.fhir.org/Consent/080d85fa-c807-42d1-a3af-b3ee70858a54
Resource Consent:
Generated Narrative: Consent 080d85fa-c807-42d1-a3af-b3ee70858a54
status: Active
scope: Treatment
category: Do Not Resuscitate
dateTime: 2021-09-01
policyRule: Common Rule Informed Consent
Provisions
Code Not for resuscitation
Entry 38 - fullUrl = https://sample.fhir.org/DocumentReference/advance-directive-123
Resource DocumentReference:
Generated Narrative: DocumentReference advance-directive-123
status: Current
type: Health concerns Document
date: 2025-08-01 10:00:00+0000
content
Attachments
ContentType Url Title application/pdf https://sample.fhir.org/DocumentReference/advance-directive-123/content Advance Directive Document
Entry 39 - fullUrl = https://sample.fhir.org/Condition/4f3d8f79-2f96-48c5-b346-d47f0c66c981
Resource Condition:
Generated Narrative: Condition 4f3d8f79-2f96-48c5-b346-d47f0c66c981
clinicalStatus: Active
verificationStatus: Confirmed
code: Impaired Mobility
onset: 2016-05-25
recordedDate: 2016-05-25
Entry 40 - fullUrl = https://sample.fhir.org/Condition/77efacd9-b5a6-4b35-9764-269017ea7567
Resource Condition:
Generated Narrative: Condition 77efacd9-b5a6-4b35-9764-269017ea7567
clinicalStatus: Resolved
verificationStatus: Confirmed
code: Fever
onset: 2013-05-25
recordedDate: 2016-05-25
Entry 41 - fullUrl = https://sample.fhir.org/CarePlan/85d57ac7-ea2d-47cf-b019-b867f876ee7c
Resource CarePlan:
A simple care plan to indicate a patient taking their weight once a day because of hypertension.
Entry 42 - fullUrl = https://sample.fhir.org/Observation/f241ac65-5eab-49a0-8b92-7fb263274110
Resource Observation:
Generated Narrative: Observation f241ac65-5eab-49a0-8b92-7fb263274110
status: Final
code: Pregnancy status
effective: 2020-01-10
value: Not Pregnant
IG © 2020+ HL7 International / Patient Care. Package hl7.fhir.uv.ips#2.0.0 based on FHIR 4.0.1. Generated 2025-09-04
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change